Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Easier injections for blinding eye diseases? new syringe study begins

NCT ID NCT07501052

First seen Apr 06, 2026 · Last updated May 22, 2026 · Updated 6 times

Summary

This study tests whether a new prefilled syringe for the drug SCD411 (a proposed biosimilar to Eylea) is easy and safe for eye doctors to use. About 33 doctors will use the syringe to treat patients with wet age-related macular degeneration, retinal vein occlusion, diabetic macular edema, or diabetic retinopathy. The main goal is to see if doctors can complete all steps without errors, especially safety-critical ones.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETIC RETINOPATHY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Center for Retina and Macular Disease

    Winter Haven, Florida, 33880, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • East Florida Eye Institute

    Stuart, Florida, 34994, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Retina Vitreous Surgeons of Central New York, PC

    Liverpool, New York, 13088, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University Retina & Macula Associates, P.C

    Lemont, Illinois, 60439, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.